KEYSER D JEFFREY 4
4 · Lantern Pharma Inc. · Filed Nov 8, 2021
Insider Transaction Report
Form 4
KEYSER D JEFFREY
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-11-04+3,200→ 3,200 totalExercise: $10.32Exp: 2031-11-04→ Common Stock (3,200 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing upon December 4, 2021.